Identification of prognostic genes and tumor-infiltrating immune cells in the tumor microenvironment of esophageal squamous cell carcinoma and esophageal adenocarcinoma

Qilin Huai(Chinese Academy of Medical Sciences & Peking Union Medical College), Shugeng Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Peng Song(Nanjing Drum Tower Hospital), Wei Guo(Army Medical University), Liang Zhao(Paraza Pharma (Canada)), Demiao Kong(Guizhou Provincial People's Hospital), Liankui Han(Guizhou Provincial People's Hospital), Yue Peng(Chinese Academy of Medical Sciences & Peking Union Medical College)
Translational Cancer Research
April 1, 2021
10.21037/tcr-20-3078
Cited by 13

Related Papers

Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2024|233
PD-1 axis expression in musculoskeletal tumors and antitumor effect of nivolumab in osteosarcoma model of humanized mouse
|Journal of Hematology & Oncology|2018|162
A review of physiological and cellular mechanisms underlying fibrotic postoperative adhesion
|International Journal of Biological Sciences|2020|114
Peripheral blood inflammatory biomarkers dynamics reflect treatment response and predict prognosis in non‐small cell lung cancer patients with neoadjuvant immunotherapy
|Cancer Science|2023|90
Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma
|Frontiers in Immunology|2021|84